4099 |
The Benefit of High Intensity Atorvastatin/Ezetimine Combination Therapy in Coronary Risk Patients with Hypercholesterolemia |
Young-Hoon Jeong |
Apr. 12. 21 |
4098 |
Is Combination Therapy Recommended for All High Risk Patients : When and Why Combination Therapy Is Needed? |
Hyuck Jun Yoon |
Apr. 12. 21 |
4097 |
Lower Is Better & Combination Is Better |
Soe-Hee Ann |
Apr. 12. 21 |
4096 |
Double Prevention of CVD Risk for Hypertensive Patients by Polypill |
Jin-Man Cho |
Apr. 12. 21 |
4095 |
Physiologic Assessment just for \"Intermediate Angiographic Stenosis\"? |
Joo Myung Lee |
Apr. 12. 21 |
4094 |
Benefits of OCT in PCI Guidance and Vulnerable Plaque Detection |
Takashi Kubo |
Apr. 12. 21 |
4093 |
My Experience of TAVR Using Cusp Overlap View for Self-Expanding THV |
Cheol Woong Yu |
Apr. 12. 21 |
4092 |
TAVR Failure Due to Structural Valve Degeneration |
Vinayak Bapat |
Apr. 12. 21 |
4091 |
My Experience Focusing on Cusp Overlap View |
Ju Han Kim |
Apr. 12. 21 |
4090 |
How to Reduce PPI Rate with Cusp Overlap Technique |
Hemal Gada |
Apr. 12. 21 |